The following is a listing of myeloma clinical trials associated with this tag.
View all active clinical trials around the US.
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
INOTUZUMAB OZOGAMICIN POST-TRANSPLANT
Stopping Maintenance Therapy in People With Multiple Myeloma in MRD-Negative Remission
STOPPING MAINTENANCE THERAPY
Study of Iberdomide in People With Multiple Myeloma Who Have Had an Autologous Hematopoietic Stem Cell Transplant (AHCT)
IBERDOMIDE AS MAINTENANCE THERAPYSparkCures Verified Accurate, up-to-date information. Learn more
A Phase 1 Study of Adding Venetoclax to a Reduced Intensity Conditioning Regimen and to Maintenance in Comb...
VENETOCLAX IN PRE- AND POST-TRANSPLANT THERAPYA Phase 1 Study of Mezigdomide (CC-92480) and Dexamethasone Post Idecabtagene Vicleucel in Relapsed Multipl...
MEZIGDOMIDE POST ABECMA TREATMENTA Phase Ib Study of Oral Decitabine/Cedazuridine as Maintenance Therapy Following Allogeneic Hematopoietic ...
DECITABINE/CEDAZURIDINE AS MAINTENANCE THERAPYA Phase III Randomized Trial for Newly Diagnosed Multiple Myeloma (NDMM) Patients Considered Frail or in a ...
TRIPLET INDUCTION + 1 OR 2-DRUG MAINTENANCEBelantamab Mafodotin, Pomalidomide and Dexamethasone for the Treatment of High-Risk Myeloma
BELANTAMAB MAFODOTIN COMBINATION THERAPYMeasurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance
MRD-GUIDED ELRANATAMAB MAINTENANCE THERAPYMinimal Residual Disease Guided Maintenance Therapy With Belantamab Mafodotin and Lenalidomide After Autolo...
BELANTAMAB MAFODOTIN OR LENALIDOMIDE MAINTENANCEPost-Transplant Maintenance Therapy With Isatuximab Plus Lenalidomide for High-Risk Multiple Myeloma Patients
POST-TRANSPLANT MAINTENANCE THERAPYPre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With...
PRE AND POST TRANSPLANT ELRANATAMABRandomized Phase 2 Study of Iberdomide Maintenance Therapy Following Idecabtagene Vicleucel CAR-T in Multip...
IBERDOMIDE VS. OBSERVATION POST IDE-CEL CAR-TThe following is a listing of clinical trials for patients with multiple myeloma who have been newly diagnosed or have not yet received treatment.
SparkCures Verified Accurate, up-to-date information. Learn more
A Phase III Randomized Trial for Newly Diagnosed Multiple Myeloma (NDMM) Patients Considered Frail or in a ...
TRIPLET INDUCTION + 1 OR 2-DRUG MAINTENANCEMeasurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance
MRD-GUIDED ELRANATAMAB MAINTENANCE THERAPYMinimal Residual Disease Guided Maintenance Therapy With Belantamab Mafodotin and Lenalidomide After Autolo...
BELANTAMAB MAFODOTIN OR LENALIDOMIDE MAINTENANCEPre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With...
PRE AND POST TRANSPLANT ELRANATAMABThe following is a listing of clinical trials for patients with multiple myeloma who have received one to two prior lines of therapy.
Stopping Maintenance Therapy in People With Multiple Myeloma in MRD-Negative Remission
STOPPING MAINTENANCE THERAPYSparkCures Verified Accurate, up-to-date information. Learn more
The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.
Stopping Maintenance Therapy in People With Multiple Myeloma in MRD-Negative Remission
STOPPING MAINTENANCE THERAPYSparkCures Verified Accurate, up-to-date information. Learn more